Credit Suisse’s iShares US Medical Devices ETF IHI Stock Holding History

Credit Suisse’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,400	Closed	-$2.6M	–	4585
2021 Q3	$2.6M	Sell	41,400 -84,600	-67%	-$5.4M	﹤0.01%	2613
2021 Q2	$7.58M	Buy	126,000 +13,200	+12%	+$763K	﹤0.01%	1751
2021 Q1	$6.21M	Buy	+112,800	New	+$6.26M	﹤0.01%	1907

Other funds holding IHI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Credit Suisse's IHI Position: Q1 2024 in Review

Credit Suisse sold out of iShares US Medical Devices ETF (IHI) in Q1 2024, closing a stake of 7,024 shares — an estimated $379K sold.

Credit Suisse first reported a position in IHI in Q2 2013 and held it in 31 quarters. The position peaked at $27.9M in Q3 2015. 584 funds tracked by Wall St. Rank hold IHI as of Q1 2024.

Credit Suisse reported no remaining iShares US Medical Devices ETF position as of Q1 2024 after selling out during the quarter.
Credit Suisse sold 7,024 iShares US Medical Devices ETF shares in Q1 2024, an estimated $379K.
Credit Suisse first reported a position in iShares US Medical Devices ETF in Q2 2013 and held it in 31 quarters.
Credit Suisse's iShares US Medical Devices ETF position peaked at $27.9M in Q3 2015.
584 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.